Laboratorios Richmond (Argentina) Performance
RICH Stock | ARS 1,670 40.00 2.45% |
Laboratorios Richmond has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -1.07, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Laboratorios Richmond are expected to decrease slowly. On the other hand, during market turmoil, Laboratorios Richmond is expected to outperform it slightly. Laboratorios Richmond right now secures a risk of 3.25%. Please verify Laboratorios Richmond SACIF coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if Laboratorios Richmond SACIF will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Laboratorios Richmond SACIF are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Laboratorios Richmond is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow | 796.9 M | |
Total Cashflows From Investing Activities | -6 B |
Laboratorios |
Laboratorios Richmond Relative Risk vs. Return Landscape
If you would invest 166,500 in Laboratorios Richmond SACIF on November 2, 2024 and sell it today you would earn a total of 500.00 from holding Laboratorios Richmond SACIF or generate 0.3% return on investment over 90 days. Laboratorios Richmond SACIF is generating 0.0554% of daily returns and assumes 3.2545% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Laboratorios, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Laboratorios Richmond Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratorios Richmond's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratorios Richmond SACIF, and traders can use it to determine the average amount a Laboratorios Richmond's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.017
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | RICH | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.25 actual daily | 28 72% of assets are more volatile |
Expected Return
0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Laboratorios Richmond is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratorios Richmond by adding it to a well-diversified portfolio.
Laboratorios Richmond Fundamentals Growth
Laboratorios Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratorios Richmond, and Laboratorios Richmond fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratorios Stock performance.
Return On Equity | 0.22 | |||
Return On Asset | 0.0427 | |||
Profit Margin | 0.11 % | |||
Operating Margin | 0.15 % | |||
Current Valuation | 21.92 B | |||
Shares Outstanding | 14.17 M | |||
Price To Earning | 480.26 X | |||
Price To Sales | 2.20 X | |||
Revenue | 16.62 B | |||
EBITDA | 2.51 B | |||
Cash And Equivalents | 348.26 M | |||
Cash Per Share | 4.31 X | |||
Total Debt | 1.19 B | |||
Debt To Equity | 39.90 % | |||
Book Value Per Share | 113.25 X | |||
Cash Flow From Operations | 3.73 B | |||
Earnings Per Share | 1.60 X | |||
Total Asset | 25.69 B | |||
About Laboratorios Richmond Performance
By analyzing Laboratorios Richmond's fundamental ratios, stakeholders can gain valuable insights into Laboratorios Richmond's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratorios Richmond has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratorios Richmond has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Laboratorios Richmond S.A.C.I.F. develops and manufactures pharmaceutical products for physicians, pharmacists, health institutions, and patients in Argentina and internationally. The company was founded in 1935 and is based in Buenos Aires, Argentina. LAB RICHMOND is traded on Buenos-Aires Stock Exchange in Argentina.Things to note about Laboratorios Richmond performance evaluation
Checking the ongoing alerts about Laboratorios Richmond for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratorios Richmond help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Laboratorios Richmond had very high historical volatility over the last 90 days |
- Analyzing Laboratorios Richmond's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratorios Richmond's stock is overvalued or undervalued compared to its peers.
- Examining Laboratorios Richmond's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratorios Richmond's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratorios Richmond's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratorios Richmond's stock. These opinions can provide insight into Laboratorios Richmond's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Richmond's price analysis, check to measure Laboratorios Richmond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Richmond is operating at the current time. Most of Laboratorios Richmond's value examination focuses on studying past and present price action to predict the probability of Laboratorios Richmond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Richmond's price. Additionally, you may evaluate how the addition of Laboratorios Richmond to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |